Current position:Home >Product >
3-(3-{4-[3-(beta-D-glucopyranosyloxy)-5-isopropyl-1Hpyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)propionamide
3-(3-{4-[3-(beta-D-glucopyranosyloxy)-5-isopropyl-1Hpyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)propionamide(666842-36-0)
- Name: 3-(3-{4-[3-(beta-D-glucopyranosyloxy)-5-isopropyl-1Hpyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)propionamide
- Synonyms:3-(3-(4-(3-(beta-D-glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)-3-methylphenoxy)propylamino)propionamide;3-(3-(4-(3-(glucopyranosyloxy)-5-isopropyl-1H-pyrazol-4-ylmethyl)-3-methylphenoxy)propylamino)propionamide;KGA-2727
- Molecular Formula:C26H40N4O8
- Molecular Weight:536.6
- CAS Registry Number:666842-36-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.666842-36-0 KGA-2727
Assay:99% Appearance:white powder Package:25kg,50kg,180kg,200kg,250kg,1000kg锛宑ustomization Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Wuhan Circle Star Chem-medical Technology co.,Ltd. [
China (Mainland)] CAS No.666842-36-0 KGA2727
Assay:98% Appearance:Solid powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:KGA2727 is a selective and potent SGLT1 inhibitor for the treatment of diabete. Its inhibition constant (Ki) values of 97 and 13,600 nM for human (h) SGLT1 and hSGLT2 respectively. It inhibited th...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 86702-10-5/(C15-H33-N3-O2.2Cl)x-
- 2054779-48-3/3,6-Di-tert-butyl-9-mesityl-10-methylacridin-10-ium tetrafluoroborate
- 1000339-68-3/2-Chloro-1-methanesulfonyl-4-(trifluoromethyl)benzene
- 914349-37-4/1-Boc-3-bromo-7-nitroindole
- 317-35-1/2-Amino-3-(2-fluorophenyl)-3-hydroxypropanoic acid
- 1430751-20-4/1-[(oxan-3-yl)methyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
- 577691-64-6/cis-4-Benzyloxycarbonylamino-3-fluoropiperidine
- 1249024-78-9/8-(Methylsulfonyl)-8-azabicyclo[3.2.1]octan-3-amine
- 887358-46-5/Methyl 4-{2-[(3,4-dichlorophenyl)amino]-2-oxoethoxy}benzoate
- 1303968-16-2/tert-Butyl 4-(2-aminoethyl)benzylcarbamate hydrochloride
- 1261898-77-4/4'-Ethoxy-5-methoxy-2'-methyl[1,1'-biphenyl]-3-ol
- 1119452-45-7/2-bromo-N-(5-chloro-2,4-dimethoxyphenyl)propanamide
- 168021-77-0/2,4-Disulfonyl-alpha-phenyl-tert-butylnitrone
- 38218-51-8/34-Methylcyanocobalamin
- 1188264-10-9/3-(4-Methylphenyl)pyrrolidine oxalate
- 1403766-91-5/1-(Azetidin-3-YL)pyrrolidin-2-one hydrochloride
- 887974-10-9/(5-(p-Tolyl)pyridin-3-yl)methanol
- 263261-65-0/Bisphenol A-13C12
- 1419101-45-3/6,6-Difluorospiro[3.3]heptane-2-carboxylic acid
- 666842-36-0/3-(3-{4-[3-(beta-D-glucopyranosyloxy)-5-isopropyl-1Hpyrazol-4-ylmethyl]-3-methylphenoxy}propylamino)propionamide
- 951892-87-8/2-Chloro-3-(3,4,5-trifluorophenyl)-1-propene
- 1446282-44-5/Bromo-PEG2-phosphonic acid
- 2049980-18-7/Azelaprag
- 1545252-82-1/2-Bromo-4-(difluoromethyl)thiazole
- 66060-05-7/Iron(2+) 2-{4-[(3-aminopropyl)amino]butyl}cyclopenta-2,4-dien-1-ide cyclopenta-2,4-dien-1-ide--hydrogen bromide (1/1/1/1)
- 1807608-40-7/Denitro-morinidazole
- 887973-82-2/5-(3,5-Dichlorophenyl)nicotinaldehyde
- 438221-56-8/2-Mercapto-4-(4-methoxyphenyl)-6-(trifluoromethyl)nicotinonitrile
- 5709-24-0/N-(2-methylpropyl)-2-(1-phenylbenzimidazol-2-yl)sulfanylacetamide
- 2101315-36-8/Gboxin